Navigation Links
Bioheart Strengthens Executive Team in Order to Accelerate Business Plan and Enhance Its Position in the Cardiovascular Stem Cell Therapy Industry
Date:8/18/2009

SUNRISE, Fla., Aug. 18 /PRNewswire-FirstCall/ -- Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.

Howard Leonhardt stated: "Karl Groth and I have worked together in the cardiovascular products industry since 1983. He has had many successful harvests of the companies he has developed. His vast experience has been an asset to the Board and will be an even greater asset to the Company's Executive Management with his increased commitment."

Karl Groth has an exceptional record of bringing medical technology companies from development stage to profitable operations and then to achieving exceptional returns for shareholders as the companies were acquired. He has demonstrated the ability to identify market opportunities and technologies, strengthen management, improve operations, focus strategy and guide companies either to acquisition by major companies in the health industry or to an IPO. After his tenure at the University of Minnesota conducting research, Dr. Groth joined Medtronic, having been recruited to help to start up the company's neuro division. His fast track manage
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. United States FDA Clears the REGEN Trial to Test Biohearts Combination Gene and Stem Cell Therapy in Heart Failure Patients
2. Bioheart, Inc. Announces Additional Funding Support
3. Bioheart, Inc. to Present at Red Chip Investor Conference in New York
4. Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
5. Bioheart, Inc. Announces Financial Results for Second Quarter 2008
6. Bioheart, Inc. Announces Results of Annual Meeting
7. Bioheart, Inc., Announces Management Change
8. Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
9. Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
10. Bioheart, Inc., Added to Russell Microcap Index
11. Bioheart, Inc. to Transfer to Nasdaq Capital Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... (PRWEB) May 21, 2013 Many have ... as contributor to acne. Recently physicians from Clinical ... mental stress on the skin, and suggested using ... reduce the chemicals produced from stress that cause acne. ... the negative feelings acne brings about, stress causes changes ...
(Date:5/21/2013)... Bed bugs have become so widespread in the past ... to chemical-based pesticides for help to completely get rid of ... solutions present, the company advised the public to kill ... According to My Cleaning Products, chemical-based pesticides are not as ... shared that the pests have already developed immunity to the ...
(Date:5/21/2013)... 2013 Possible mold re-infestation in Guilemtte School ... a report from eagletribune.com posted May 14, 2013, the state ... result is positive, My Cleaning Products offered a tip ... , It was said in the Eagle Tribune report (5.14.13) ... campus sparked after a first-grade classroom was closed due to ...
(Date:5/20/2013)... , May 20, 2013 ... (USDA) Agricultural Research Service (ARS) in treatment of ... , Trials to begin in the ... drug delivery technology company Phosphagenics Limited (ASX: ... of Agriculture,s (USDA) Agricultural Research Service (ARS) to develop ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3Phosphagenics Signs Research Agreement with the Agricultural Research Service 2
... FOCUS ON ALS CLINICALS AND DRUG DEVELOPMENT, ... Inc. (Amex: CUR ) announced that Dr. ... Vice President, Research. He will be,working with Dr. ... manage the company,s upcoming clinical trial for ALS,(Amytrophic ...
... to Advance Clinical Development Of Lead Drug Candidates, ... today announced the,closing of a CDN $45 million ... a,new investor, Mitsubishi Tanabe Pharma Corporation ("MTPC"), and ... Advanced Life,Sciences Fund Inc., Caisse de Depot et ...
... 30 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX:,MS), a leading ... that Mr. Kevin Giese, President and CEO, will present ... New York., WHEN: Wednesday August 6th ... Hotel, New York About BioMS Medical Corp., ...
Cached Biology Technology:Neuralstem Fills Key Product Development Position 2Cytochroma Closes $45 Million Series C Financing 2Cytochroma Closes $45 Million Series C Financing 3BioMS Medical to present at BMO Healthcare Conference 2
(Date:5/20/2013)... to the antibiotic colistin are also commonly resistant ... according to a study in mBio , ... for Microbiology. Cross-resistance to colistin and host antimicrobials ... against bacterial attack, could mean that patients with ... a crippled immune response. Colistin is a last-line ...
(Date:5/20/2013)... planning grant will help establish the Center for Advanced ... University of Illinois at Urbana-Champaign and Worcester Polytechnic Institute ... to research in drying moist, porous materials such as ... chemical products; textiles; and biopharmaceuticals," said Hao Feng, a ... nutrition and the Illinois site director. , According to ...
(Date:5/19/2013)... strain of electricity-producing bacteria that can grow using hydrogen ... as its sole source of carbon. Researchers at ... the 113th General Meeting of the American Society for ... production solely on hydrogen," says Amit Kumar, a researcher ... part of the Lovley Lab Group at the university. ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3NSF approves planning grant for Center for Advanced Research in Drying 2
... has pinpointed a natural ingredient of human blood that ... AIDS, from infecting immune cells and multiplying. The virus ... HIV to full-blown AIDS and—because it works in a ... development of another class of drugs in the fight ...
... of non-human primates infected with the influenza virus that killed ... has found a critical clue to how the virus killed ... 2007) in the journal Nature, a team led by University ... - modern history's most savage influenza strain - unleashes an ...
... UCLA scientists have devised a novel way to correct abnormal ... Splicing edits out the punctuation from a cell’s genetic ... cell. Using new technology made by Gene Tools of ... abnormal splice. The technique prevents the cell from seeing ...
Cached Biology News:Discovery of an HIV inhibitor in human blood points to new drug class 2Discovery of an HIV inhibitor in human blood points to new drug class 3Study uncovers a lethal secret of 1918 influenza virus 2Study uncovers a lethal secret of 1918 influenza virus 3
Mouse monoclonal [CP23] to Ricin communis ( Abpromise for all tested applications)....
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Rabbit anti-NFkB p105/p50 (Ser337) Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Biology Products: